This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignees: D.e. Shaw Research, LLC, Relay Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 31 
1 out of 14 Years Active: 2026
Title: Ravi Kurukulasuriya: Innovator in Pharmaceutical Research
Introduction
Ravi Kurukulasuriya is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds and methods for treating various disorders. Although he currently holds no granted patents, his work continues to influence the industry.
Latest Patent Applications
Ravi's latest patent applications include "SRC INHIBITORS AND USES THEREOF." This invention relates to compounds and methods useful for inhibiting non-receptor tyrosine-protein kinase Src ('Src'). The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders. Another application is "PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF." This disclosure relates to novel compounds and pharmaceutical compositions, as well as methods for inhibiting the activity of PI3Kα enzymes. It further includes methods for treating disorders associated with PI3Kα signaling using the compounds and compositions described.
Conclusion
Ravi Kurukulasuriya is a notable figure in the realm of pharmaceutical innovation, with a focus on developing new therapeutic methods. His ongoing research and patent applications reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile